Recovery Prediction of Motor Function Using Neuroimaging Techniques in Subacute Stroke Patients
Sponsor
Samsung Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT03365596
Collaborator
(none)
70
1
37
1.9
Study Details
Study Description
Brief Summary
Prediction of recovery from stroke can assist in the planning of impairment-focused rehabilitation. To achieve better prediction for clinical purposes, this study investigated a new prediction model with low inter-individual variability and high accuracy using neuroimaging techniques.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
70 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Functional MRI and DTI Study for Brain Network Analysis and Recovery Prediction in Subacute Stroke Patients
Actual Study Start Date
:
Jun 1, 2017
Anticipated Primary Completion Date
:
Jun 30, 2020
Anticipated Study Completion Date
:
Jun 30, 2020
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Subacute stroke
|
Other: Conventional therapy
According to the status of a patient, optimized therapy will be applied.
|
Outcome Measures
Primary Outcome Measures
- Fugl-Meyer Assessment score at 3 months after stroke onset [3 months after stroke onset]
Measurement of motor function of upper and lower extremities
Eligibility Criteria
Criteria
Ages Eligible for Study:
19 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
First-ever stroke patients
-
Unilateral stroke
-
Subacute stage (less than 4 weeks)
Exclusion Criteria:
-
Major active neurological disease or psychiatric disease
-
A history of seizure
-
Metallic implants in their brain
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Samsung Medical Center | Seoul | Korea, Republic of |
Sponsors and Collaborators
- Samsung Medical Center
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT03365596
Other Study ID Numbers:
- 2017-02-107
First Posted:
Dec 7, 2017
Last Update Posted:
Jul 12, 2019
Last Verified:
Jul 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Samsung Medical Center
Additional relevant MeSH terms: